Procedural advice for post-orphan medicinal product designation activities: Guidance for sponsors

Human medicines European public assessment report (EPAR): Nexium Control, esomeprazole, Date of authorisation: 26/08/2013, Revision: 20, Status: Authorised

Falsified medicines: overview

Committee on Herbal Medicinal Products (HMPC): Work Plan 2025

One Health: EU agencies unite to tackle azole fungicide resistance in Aspergillus fungi

Procedural advice for orphan medicinal product designation: Guidance for sponsors

Human medicines European public assessment report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop), irbesartan, Date of authorisation: 19/01/2007, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Celldemic, zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures), Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised

Referral: Metamizole-containing medicinal products, metamizole Article 107i procedures European Commission final decision, 22/11/2024, 29/01/2025

Human medicines European public assessment report (EPAR): Edarbi, azilsartan medoxomil, Date of authorisation: 07/12/2011, Revision: 12, Status: Authorised